Article
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication
2022-03-07
Abstract excerpt
New therapeutic targets are a valuable resource in the struggle to reduce the morbidity and mortality associated with the COVID-19 pandemic, caused by the SARS-CoV-2 virus. Genome-wide association studies (GWAS) have identified risk loci, but some loci are associated with co-morbidities and are not specific to host-virus interactions. Here, we identify and experimentally validate a link between reduced expression...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e5c2704b-c11f-522b-b852-a15b5611a417
- DOI
- 10.1101/2022.03.06.483172
